Webinar Series
An important part of this research project is to look at the current climate of PrEP access, rollout and uptake. Once informed by community members, we want to contribute to bettering the delivery and provision of PrEP when long-acting options hit the market. In working to understand the current status of PrEP, The Future of PrEP is Now team has begun a webinar series. This series includes conversations with leading 2SGBQM community members, service providers, and healthcare professionals sharing their experiences and opinions about daily and long-acting PrEP.
Part 1
PrEP: Where Are We Now?
Learn about current PrEP options and regimens, barriers to access, and what gaps exist in HIV prevention due to intersectional, systemic discrimination. Community leaders and academics from key undereached populations share their perspectives on PrEP perceptions, access, and uptake within their communities.
Part 2
PrEP: Where Are We Going?
Learn about the future of PrEP, in particular the new injectable PrEP options for people not currently reached by oral PrEP. We discuss the rollout of oral PrEP and how to build strong, community-centred plans to ensure that those who may benefit from long-acting PrEP know about it, can access it, and feel comfortable doing so.
Learn more about PrEP options available now
03/11/2019
PrEP to Prevent HIV: Your Questions Answered
If you want to take PrEP, you have to talk to a medical professional. Any doctor can prescribe PrEP and some nurses are also licensed to prescribe it.
03/14/2019
Is PrEP Right for Me?
PrEP is used by people who are HIV negative to help prevent them from getting HIV. PrEP stands for pre-exposure prophylaxis.
Where to get PrEP (or other services for sexual health or harm reduction)
This website is for people looking for HIV, hepatitis C, sexual health or harm reduction services in Canada, with additional resources to support their journey to health and wellness. Search for services by location or by type of service.
Learn more about long-acting PrEP
08/31/2022
Worth a shot: Injectable PrEP for HIV Prevention
A new long-acting injectable form of PrEP was recently approved for use in the United States and may become licensed for use in Canada in the future.
11/29/2022
Where is injectable PrEP is currently approved? (CAB-LA/injectable PrEP worldwide registration)
Find out where injectable PrEP is currently approved.
Latest News
A Promising New Way to Prevent HIV Infections
Why a new injectable drug is a breakthrough, and how Canadian scientists are improving access to it.
Long-acting injectable PrEP is a big step forward in HIV prevention
One year ago, the United States approved a new injectable drug that prevents HIV.
WHO recommends long-acting cabotegravir for HIV prevention
New WHO guidelines advise countries to deliver long-acting cabotegravir as part of comprehensive approach to HIV prevention